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The production of IL-1-family cytokines such as IL-1β and IL-18 is finely regulated
by inflammasome activation after the recognition of pathogens associated molecular
pattern (PAMPs) and danger associated molecular patterns (DAMPs). However, little is
known about the helminth-derived molecules capable of activating the inflammasome.
In the case of the helminth trematode Fasciola hepatica, the secretion of different
cathepsin L cysteine peptidases (FhCL) is crucial for the parasite survival. Among
these enzymes, cathepsin L3 (FhCL3) is expressed mainly in the juvenile or invasive
stage. The ability of FhCL3 to digest collagen has demonstrated to be critical
for intestinal tissue invasion during juvenile larvae migration. However, there is no
information about the interaction of FhCL3 with the immune system. It has been shown
here that FhCL3 induces a non-canonical inflammasome activation in dendritic cells
(DCs), leading to IL-1β and IL-18 production without a previous microbial priming.
Interestingly, this activation was depending on the cysteine protease activity of FhCL3
and the NLRP3 receptor, but independent of caspase activation. We also show
that FhCL3 is internalized by DCs, promoting pro-IL-1β cleavage to its mature and
biologically active form IL-1β, which is released to the extracellular environment. The
FhCL3-induced NLRP3 inflammasome activation conditions DCs to promote a singular
adaptive immune response, characterized by increased production of IFN-γ and IL-13.
These data reveal an unexpected ability of FhCL3, a helminth-derived molecule, to
activate the NLRP3 inflammasome, which is independent of the classical mechanism
involving caspase activation.
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INTRODUCTION
Fasciolosis, caused by the helminth parasite F. hepatica is a
chronic disease that affects the liver of cattle all over the world.
It is estimated that this disease causes huge annual economic
losses in livestock, due to a reduction in the production of milk,
wool and meat in cows and sheep (1, 2). In addition, the World
Health Organization (WHO) has reported that ∼2.4 million
people are infected by this parasite worldwide; and fasciolosis
has recently been declared as an emerging disease in humans
with an increased number of cases in some regions of the planet
(3, 4).Mammals (human and cattle) are infected by the ingestion
of the metacercariae, a parasitic form encystic in aquatic plants.
At the early stage after infection, the parasites excyst in the small
intestine. Then, juvenile flukes called newly excysted juveniles
penetrate through the host intestine wall and migrate across the
peritoneal cavity, until they reach the liver, which is the target
organ of the infection (5).
F. hepatica has developed strategies for the evasion of the host
immune response. It has been determined that different antigenic
preparations of this parasite such as total extract (TE), F. hepatica
tegumental antigen (FhTeg) and excretory-secretory products
(ESP) decrease the activation state of DCs, induced by LPS (6–
8). It has been established that the F. hepatica proteins cathepsin
L1 (FhCL1), gluthation transferase (FhGST), and Kunitz type
molecule (FhKTM) have a modulating effect on DCs, which
leads to the suppression of the adaptive immune responses Th1
and/or Th17 (9, 10). In line with this, in our laboratory, it
has been demonstrated a correlation between PDL-2 expression
in macrophages and the promotion of Th2 response, which in
turn inhibits Th1 profile during infection with F. hepatica (11).
These results suggest that there would be molecules within the
products derived from the parasite, that promote inflammatory
type responses. According to this hypothesis, data from other
authors have demonstrated that a mucin-like peptide derived
from F. hepatica has immunostimulatory properties, increasing
the ability of DCs to promote IFN-γ responses in allogeneic
splenocytes (12).
Despite the existence of these parasite molecules that
promotes inflammatory responses, the parasite infection mainly
induces Th2 and T reg cells, suppressing a Th1 type response.
However, an exacerbated Th2 response could also be deleterious
for the parasite.
In a recent study, the chronicity of helminth infection has been
related to the ability of the intestinal parasite Heligmosomoides
polygyrusbakeri (Hp) to induce IL-1β secretion, which in turn
inhibits IL-33 and IL-25, resulting in the control of an excessive
Th2 response (13).
It is well-known that two signals are required for
inflammasome-dependent IL-1β cytokine production. The
first signal involves cellular activation by microbial stimuli or
endogenous danger signals which activate pattern recognition
receptors such as the Toll-like receptor (TLR), leading to the
activation of the transcription factor NF-κB and consequently
the synthesis of pro-IL1β and components of the inflammasome
complex. The second signal is the activation of the inflammasome
multiprotein complex by different stimuli such as ATP, silica,
amyloid-β peptide, among others, that leads to the autocatalysis
of pro-caspase-1, which cleaves the pro-IL-1β into bioactive
IL-1β form (14).
Among the inflammasomes, the pyrin domain containing
nod-like receptor 3 (NLRP3) inflammasome, is the most
studied because it plays a major role in the immune response
against different pathogens such as viruses (15–17), bacteria
(18), protozoan parasites (19), and fungal pathogens (20, 21).
However, the role of inflammasome after helminth product
stimulation or helminth infection, is less clear so far. In relation
to this, there is a report showing that soluble eggs antigen (SEA)
from Schistosomamansoni induces the inflammasome activation,
increasing IL-1β secretion, after TLR priming on dendritic cells
(DCs) (22). In contrast, a secreted peptide from F. hepatica,
the helminth defense molecule 1 (FhHDM-1) prevents NLRP3
activation and IL-1β production (23).
As regards the molecules secreted by F. hepatica during its
migration, cathepsin L family, represents 80% of the peptidases
with cysteine protease activity. Cathepsins are critical for the
parasite survival, since they are able to digest the protein
contents of the blood, including haemoglobin, albumin, and
immunoglobulin. FhCL1 and FhCL2 are predominant in mature
stages, while FhCL3 is mainly expressed in the juvenile form or
invasive stage (24, 25). Although both, FhCL2 and FhCL3 have
shown collagenolytic activity, FhCL3 has demonstrated greater
ability to digest type I and II collagens compared to FhCL2. It
has been reported that FhCL1 induces some pro-inflammatory
mediator secretion such as IL-6, IL-12p40 (26) and macrophage
inflammatory protein 2 (MIP-2) with enhanced CD40 expression
in DCs (9). In addition, these immunomodulatory functions
were shown to be dependent on TLR4 and on its cystein
protease activity (9). Although FhCL3 is an important part of
the proteolytic machinery of F. hepatica, its interaction with the
immune system is unknown so far.
In the present study, we investigate the capacity of an active
recombinant FhCL3 to modulate murine DC functions. We
show an unexpected ability of FhCL3 to induce IL-1β and IL-18
secretion by DCs, which was dependent on its enzymatic activity
and NLRP3 activation. Surprisingly, the lack of priming as well
as caspase1/11 requirement for IL-1β production by FhCL3-
treated DCs, indicate that alternative inflammasome activation
mechanisms are carried out by this parasite molecule. Here
we demonstrate that FhCL3 is internalized and targeted to the
cytosol, where the pro-IL-1β cytokine is cleaved to its mature
and biologically active form. Besides, FhCL3-dependent NLRP3
inflammasome alternative activation was associated with reactive
oxygen species (ROS) production, lysosomal acidification and
potassium channel efflux. Finally, we show that the interaction
of DCs with FhCL3 has consequences on adaptive immune
response, since it confers a unique expression pattern of cytokines
IFN-γ and IL-13 that could be protective in this parasitosis or in
other helminth infections.
MATERIALS AND METHODS
Mice
Six- to eight-week-old inbred female C57BL/6 mice indicated
as wild type (WT) along the manuscript, were obtained from
the Faculty of Veterinary Sciences, National University of Litoral
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(UNL, Argentina). CASP1/11 KO (B6N.129S2-Casp1tm1Flv/J)
and NLRP3 KO (B6.129S6-Nlrp3/Jtm1Bhk) mice, on a C57BL/6
background, were purchased from Jackson Laboratory (Bar
Harbor, ME, USA). The BALB/c mice used were obtained
from the Comisión Nacional de Energía Atómica (Buenos
Aires, Argentina).
All animal experiments were approved by and conducted in
accordance with guidelines of the committee for Animal Care
and Use of the Faculty of Chemical Sciences, National University
of Córdoba (Approval Number HCD 1637) in strict accordance
with the recommendation of the Guide to the Care and Use of
Experimental Animals published by the Canadian Council on
Animal Care (OLAW Assurance number A5802-01).
Production of FhCL3 and rvFhCL3
Active FhCL3 and recombinant variant rvFhCL3 were produced
in the yeast Hansenula polymorpha as previously described (25,
26). rvFhCL3 has a Trp67Leu substitution which drastically
reduces enzyme activity toward P2-Pro and P3-Gly substrates
and renders the enzyme unable to digest type I collagen
(27). Recombinant pro-peptidases were secreted to the culture
media, and recovered by 20–30 fold concentration of culture
supernatants by ultrafiltration with a 10 kDa cut-off membrane.
The pro-enzymes were auto-catalytically activated to the mature
form by incubation for 2 h at 37◦C in 0.1M sodium citrate buffer
(pH 5.0) with 2mM DTT and 2.5mM EDTA, dialyzed against
PBS pH 7.3 and stored at −20◦C. The protein concentration
was assessed by the bicinchoninic acid (BCA) method (27).
Endotoxins were removed by using polymyxin B columns
(Thermo Fisher Scientific, Waltham, MA, USA), according to
the manufacturer’s instructions. The presence of endotoxins
was assessed before and after removing endotoxins using
the Chromogenic Limulus Amebocyte Lysate QCL-1000 Assay
(Lonza, Walkersville, MD, USA) following the manufacturer’s
instructions. Both proteins (active FhCL3 and rvFhCL3), after
polymyxn B columns, were revealed to have endotoxin levels
similar to those of background and complete RPMI 1,640
medium (supplemented with 5% heat-inactivated fetal bovine
serum, 40µg/ml gentamicin, 2mM L-glutamine, and 50µM 2-
mercaptoethanol), so they were taken to be endotoxin free (data
not shown).
FhCL3 Enzymatic Activity Characterization
The FhCL3 used in this study is a functionally active
recombinant protein (Length: 226 aa, Mass (kDa): 26) expressed
in yeast and isolated as previously described (25, 28). FhCL3
exhibited an enzyme activity detected by a fluorescence
assay using the synthetic fluorogenic peptide Tos-GPR-AMC.
When this peptide is hydrolyzed it releases the fluorescent
group 7-amino-4-methyl coumarin (AMC). The measurement
of fluorescence (RFU) was performed at 60-s intervals for
20min (Supplementary Figure 1A). Furthermore, the analysis
of recombinant FhCL3 by The MALDI-TOF mass spectrum,
revealed two peaks: one, the most abundant of 29 kDa and
another of 38.6 kDa corresponding to the expected MW
values for the mature enzyme and pro-enzyme, respectively
(Supplementary Figure 1B).
DCs Generation and Stimulation
DCs were generated as previously described, with slight
modifications (6). Mice were sacrificed by cervical dislocation,
and bone marrow was collected from femurs and tibiae of mice,
and the cells were cultured with 7.5% of supernatant from GM-
CSF, which produced J558 cells (20 ng/ml final concentration
in the plate) in 8 days. After this time period, the expression
of CD11c and MHCII were quantified by flow cytometry using
FITC- or PE-conjugated Ab purchased from BD Biosciences, San
Jose, CA, USA. Harvested cells comprised between 75 and 90%
DCs (MHCII+, CD11c+). DCs viability was evaluated by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay (Sigma-Aldrich St. Louis, MO, USA) after all treatments
it was about 90%. Besides, Lactate dehydrogenase (LDH) release
was measured by a colorimetric assay kit (Wiener Lab) according
to the manufacturer’s protocol and FhCL3 treatment did not
induce cytotoxicity in DCs.
Stimuli and Inhibitors Treatments
At day 8 of differentiation, DCs were treated with FhCL3
(10µg/ml), rvFhCL3 (10µg/ml), LPS from E. coli serotype
055:B5 (100 ng/ml; Sigma-Aldrich,St. Louis, MO, USA) for 18 h
and/or ATP (5mM; Sigma-Aldrich St. Louis, MO, USA) the
last 30min of culture. In some cases, cells were pretreated
with different inhibitors: a pan caspase inhibitor, carbobenzoxy-
valyl-alanyl-aspartyl-[O-methyl]- fluoromethylketone (Z-VAD-
FMK, 20µM, during 1 h), a NADPH oxidase inhibitor,
diphenyleneiodonium chloride (DPI, 20µM, for 3 h), KCl
(50mM, for 90min), chloroquine (5mM for 1 h), all reagents
were purchased in Sigma-Aldrich St. Louis, MO, USA. After
pretreatment, the DCs were washed. Then, the cells and
supernatants were collected for performing different techniques.
The number of cells used for the different techniques was: 4× 105
cells/well for ELISA and Flow Cytometry, and 1 × 106 cells/well
for qPCR, Western blot and Confocal Microscopy.
Flow Cytometry
After the FhCL3 and LPS treatments as described above, the
expression of surface molecules on DCs was quantified by
flow cytometry using anti-CD11c, anti-MHCI, anti-MHCII, anti-
CD40, anti-CD80, and anti-CD86, all purchased from (BD
Bioscience, San Jose, CA, USA). For the exclusion of dead cells,
we used the Zombie Aqua fixable viability kit (BioLegend, San
Diego, CA, USA). Samples were collected using the FACSCanto
II and FACS LSR Fortessa (BD Biosciences, San Jose, CA, USA)
and data were analyzed using the Flow Jo Software.
Cytokine Measurement
IL-6, IL-12p70, TNF, IL-10, IL-4, and IFN-γwere purchased from
BD Pharmingen, San Jose, CA, USA; IL-1β, IL-18, and IL-13
from Thermo Fisher Scientific, Waltham, MA, USA and IFN-
β from BioLegend, San Diego, CA, USA. All cytokines were
measured in culture supernatants by capture ELISA following the
manufacturer’s guidelines.
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Western Blot
Conditioned DCs as described above were treated with RIPA
buffer, analyzed by 10% SDS-PAGE and transferred to a
nitrocellulose membrane. After blocking with 5% milk, the
membranes were incubated overnight at 4◦C with primary
rabbit and mouse monoclonal antibodies: anti-IκB-α Antibody
(Cell Signaling Technology, Danvers, MA, USA), anti NF-kB
p65 Polyclonal Antibody (ThermoFisher Scientific Waltham,
MA, USA), and Anti-β-actin (Abcam, Cambridge, UK). β-
actin was used as loading control. The sheets were revealed by
incubation with corresponding IRD Fluor 800-labeled IgG or
IRD Fluor 680-labeled IgG secondary antibodies (LI-COR Inc.,
Lincoln, NE, USA) for 1 h at room temperature. After washing,
the membranes were scanned with the Odyssey CLx Infrared
Imaging System (LI-COR, Lincoln, NE, USA) at a wavelength
of 700–800 nm. Densitometric analysis was performed using
FIJI/ImageJ software.
Confocal Microscopy
FhCL3 were labeled with an Alexa Fluor 488 labeling protein
kit (Molecular Probes- Thermo Fisher Scientific, Waltham,
MA, USA) (29). DCs were incubated with Alexa Fluor
488-labeled-FhCL3 for 2, 4, or 18 h in RPMI complete
medium. Then, the cells were fixed by incubation with 4%
paraformaldehyde and subsequently permeabilized with 0.1%
Triton-X/PBS. After this, cells were incubated for 1 h at room
temperature with primary antibody specific for early endosome
antigen, EEA-1 (Abcam, Cambridge, UK) or LAMP-1/CD107a
(R&D Systems, MN, USA) diluted in 1% FBS/PBS. Following
three washes with 1X PBS, the cells were incubated with
secondary antibody, Alexa Fluor 647-conjugated Goat anti-
Rabbit IgG (Thermo Fisher Scientific, Waltham, MA, USA)
or Northern Lights 557–conjugated Goat anti-Rat IgG (R&D
Systems, MN, USA) and then stained with Hoechst (1µg/ml in
PBS) to detect cell nuclei. Cells were examined either confocal
microscope (Olympus FV1200), and images were analyzed using
FIJI/ImageJ software.
Quantitative Real-Time-PCR (q-PCR)
RNA was extracted from DCs by the Trizol reagent (Invitrogen,
ThermoFisher Scientific, Waltham, MA, USA) and reverse-
transcribed into cDNA by using Revert Aid First Strand
cDNA Synthesis (Fermentas- ThermoFisher Scientific,
Waltham, MA, USA). Transcripts were quantified by real-
time quantitative PCR on an StepOnePlusTM Real-Time System
using SYBR Green (ThermoFisher Scientific Waltham, MA,
USA) with the following primers (all primers listed in the 5′
to 3′ orientation): Il-1b GCAACTGTTCCTGAACTCAACT
(forward) and ATCTTTTGGGGTCCGTCAACT (reverse),
Actb CGCCACCAGTTCGCCATGGA (forward) and
TACAGCCCGGGGAGCATCGT (reverse). Relative expression
was calculated using Delta-Cq method (RQ = E−(1Cq)), and
normalized to the level of unstimulated DCs. The cycling
conditions included a hot start at 95◦C for 10min, followed by
40 cycles at 95◦C for 15 s and 60◦C for 1 min.
Direct Effects of FhCL3 on
Recombinant Pro-IL-1β
Murine IL-1β standard (Thermo Fisher, ScientificWaltham,MA,
USA) at a concentration of 500 pg/ml and murine pro-IL-1β
standard (Thermo Fisher, Scientific Waltham, MA, USA) at a
concentration of 1,000 pg/ml were mixed separately with FhCL3
(1µg/ml) or rvFhCL3 (1µg/ml) in a reaction buffer containing
0.1M sodium phosphate buffer, pH 6.0, 1mM DTT and 1mM
EDTA. The samples were kept in the incubator for 2 h, at 37◦C.
Then, the determination of mature IL-1β was performed by
capture ELISA and Western blot. For ELISA, an IL-1β Mouse
Uncoated ELISA Kit (Thermo Fisher, Scientific Waltham, MA,
USA) was used. For western blot anti-IL-1β antibody (Cell
Signaling Technology, Danvers, MA, USA) and a mouse IL-1
beta /IL-1F2 Antibody (R&D Systems, MN, USA) were used as
primary antibodies, to detect IL-1β and pro-IL-1β, respectively.
IRD Fluor 800-labeled IgG (LI-COR Inc., Lincoln, NE, USA) was
as and secondary antibody.
ROS Production
To evaluate the intracellular ROS, cytoplasmic ROS (cROS) and
mitochondrial (mROS), DCs from each experimental condition
were collected and washed with PBS 2% FBS. First, cells were
stained with APC labeled anti-CD11c (BioLegend) and with
PerCP labeled anti-MHCII (BD Pharmigen, San Diego, CA)
antibodies for 20min at 4◦C. After that, DCs were incubated with
5µM of a MitoSOX TM Red probe (Thermo Fisher, Scientific
Waltham, MA, USA) for mROS or 20µM H2DCFDA probe
(Sigma Aldrich, St. Louis, MO, USA) for cROS detection for
20min at 37◦C. Finally, these cells were collected using the
FACSCanto II (BD San José, CA, USA), and data were analyzed
using the FlowJo Software.
Allogeneic Mixed Lymphocyte Reaction
DCs from C57BL/6 mice (2 × 104 cells/well) unstimulated or
treated with FhCL3 (10µg/ml) were cultured for 18 h. Collected
cells were cultured with splenocytes from BALB/c mice (2 ×
105 cells/well) 0(10). After 5 days of culture, cells were collected,
stimulated with PMA/Ionomycin for 4 h and analyzed by flow
cytometry. While, the supernatants were analyzed for IFN-γ,
IL-4, and IL-13 production by ELISA.
In vivo DCs Treatment
DCs from C57BL/6 mice were treated for 18 h as described
above, washed twice with PBS, and injected intraperitoneally in
C57BL/6 mice (1 × 106 cells/mice). After 7 days, inguinal lymph
nodes (iLN) were recovery. Suspensions of lymphocytes were
adjusted to 5 × 105 cells/mL and cultured in 96-well plates in
medium alone or in the presence of 10µg/mL of FhCL3 for
48 h. Then, the cells were stimulated with PMA/Ionomycin for
4 h and analyzed by flow cytometry. For IFN-γ, IL-4, and IL-
13 detection by ELISA, supernatans were collected after 48 h of
FhCL3 re-stimulation.
Statistical Analysis
The measurement of cytokines in the DCs supernatants was
performed for three wells per culture, with 3 to 5 cultures being
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included in each group and the data expressed as means ±
standard deviation. In some experiments data were analyzed
by one or two-way ANOVA followed by Tukey or Bonferroni’s
post-test for comparing more than two groups. GraphPad Prism
versión 6.01 was used for statistical comparisons. P-values of
∗
< 0.05, ∗∗ < 0.01 or ∗∗∗ < 0.001 were considered to be
statistically significant, depending on the experiment.
RESULTS
FhCL3 Induces IL-1β and IL-18 Production
Depending on its Cysteine
Protease Activity
Despite the evidences showing that different molecules from
F. hepatica, such as cysteine protease cathepsin L1 (FhCL1),
glutathione transferase (FhGST), and Kunitz type molecule
(KTM) are able to regulate DCs activation (9, 10), there is no
information about the capacity of FhCL3, which is expressed in
the invasive stage of this parasite, to modulate DCs functions.
To make progress in the knowledge into the interaction
between FhCL3 and DCs, we evaluated the ability of this protein
to modify the maturation status of these cells. In the presence
of FhCL3, immature DCs expressed increased levels of MHC
class II molecules in comparison to untreated DCs (MFI fold
increase FhCL3 vs. untreated DCs p < 0,001, Figure 1A), while
the expression of co-stimulatory molecules CD40, CD80, and
CD86 was not modified (Supplementary Figure 2A). FhCL3
stimulation of DCs did not induce IL-6, IL-12p70, IFN-β, TNF, or
IL-10 production. Surprisingly, after this treatment, an increase
in IL-1β and IL-18 secretion was detected as compared to
untreated DCs (Figure 1B). Furthermore, the specific cysteine
protease activity of FhCL3 was critical for IL-1β and IL-18
production, since the recombinant variant of FhCL3 (rvFhCL3),
has a specific change in the amino acid sequence at the active site
that abolishes FhCL3 unique ability to cut P2-P3 Pro-Gly residues
but not completely inactivate the enzyme (25), it was unable to
induce IL-1β and IL-18 secretion (Figure 1C).
IL-1β secretion depends on the synthesis of pro-IL-1β after
canonical activation of NF-kB therefore, we wondered if FhCL3
could induce NF-kB activation. As it was previously reported,
LPS induced p65 (30) and IkB-α (31) degradation between
10 and 30min after DCs stimulation. However, the bands
corresponding to p65 and IkB-α, were not modified between
10 and 30min after FhCL3 treatment in comparison with
unstimulated DCs (Supplementary Figure 2B), which indicates
the lack of activation of NF-κB.
Altogether these data indicate that FhCL3 promotes the IL-
1β and IL-18 release in DCs in the absence of priming or NF-κB
activation. However, this effect depends on the enzymatic activity
of FhCL3.
FhCL3 Is Internalized by DCs and Targeted
to the Cytosol
In order to evaluate whether FhCL3 is uptaked by DCs or not,
these cells were treated with an Alexa fluor 488-labeled FhCL3
(Green). Confocal microscopy analysis revealed that after 2 h,
labeled FhCL3 was internalized mostly to the cytosol, since the
labeled-protein was located in early endosome antigen (EEA)-
negative compartment (Figure 2A). In addition, a weak co-
localization of FhCL3 with LAMP positive compartments was
observed at 4 or 18 h of culture (Figures 2B,C).
We also observed that the level of Alexa fluor 488-labeled
FhCL3 was substantially unaltered up to 18 h (Figure 2C). Series
of confocal fluorescence pictures taken along the z-axis (z-stack)
of labeled FhCL3-treated DCs, confirm the presence of green
fluorescence (FhCL3) inside the cells (Figure 2A). These results
show that FhCL3 is endocyted by DCs and remains unchanged
for at least 18 h mainly in the cytosol of the cells.
FhCL3 Induces the Expression, Maturation,
and Release of IL-1β in the Absence of
other Stimuli
In order to know if FhCL3 is able to synergize with other stimuli
causing the activation of the inflammasome, we cultivated DCs
with FhCL3 in the presence or absence of LPS or ATP. The
addition of LPS or ATP to FhCL3-stimulated DCs, did not
modify IL-1β or IL-18 secretion compared to those produced by
FhCL3-treated DCs (Figure 3A). As previously reported, upon
LPS plus ATP DCs stimulation, an increase in IL-1β and IL-18
was observed (32), meanwhile the LPS stimulation only enhanced
IL-1β production (Figure 3A). During inflammasome activation,
the existence of a first signal has been reported as an essential
step for the synthesis of the pro-form of IL-1β (among other
components of the inflammasome), otherwise there would be
no availability of substrate for caspase-1 to produce the active
form of IL-1β (20, 33). Unlike IL-18, which is constitutively
expressed in murine macrophages, dendritic cells, endothelial
cells, intestinal epithelial cells, and keratinocytes under steady
state (34), IL-1β requires an induction for its biosynthesis.
This event is normally promoted via TLR ligands and other
cytokines, leading to the synthesis of pro-IL-1β (35). We evaluate
IL-1β mRNA expression by qPCR after 2 and 4 h of culture.
Figure 3B shows that similarly to LPS, FhCL3 induces IL-1β gene
transcription in DCs, compared to untreated cells (Figure 3B).
In vitro studies have shown that some proteases, such as
neutrophil elastase, are able to process the pro-IL-1β into mature
IL-1β (36). In addition, in the view of the fact that the enzymatic
activity of FhCL3 was necessary to induce the biologically active
form of IL-1β, we hypothesized that the FhCL3 cysteine protease
activity, might be essential for the cleavage of pro-IL-1β. To
evaluate this, we performed two approaches in a free cell system.
First, a murine recombinant of IL-1β or pro-IL-1β was separately
incubated with FhCL3 or rvFhCL3, in a slightly acid medium.
At the end of the incubation time, IL-1β was detected by
capture ELISA. The detection of mature IL-1β was possible in
those wells where pro-IL-1β was treated with the enzymatically
activate FhCL3. In contrast, in those cases where pro-IL-1β was
treated with rvFhCL3, IL-1β was not detected (Figure 3C). In the
second strategy, upon addition of FhCL3 to pro-IL-1β, a band
corresponding to 17 kDa IL-1β form was detected by western
blot, In contrast, when the rvFhCL3 was added to pro-IL-1β,
the band corresponding to mature IL-1β, was not observed.
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FIGURE 1 | Active FhCL3 induces IL-1β and IL-18 production in DCs. (A) DCs from C57BL/6 mice were incubated with medium, FhCL3 (10µg/ml) or LPS
(100 ng/ml) for 18 h. Representative histograms show the cell surface expression of MHCII. Unstained cells (gray histograms), isotype controls (dotted lines), and
FhCL3 or LPS-stimulated cells (black lines). Values represent the mean fluorescent intensity (MFI) and the percentage of positive cells. Bar graphs depict fold change
MFI respect to unstimulated DCs (B) IL-6, IL-12p70, IFN-β, TNF, IL-10, IL-1β, and IL-18 production were detected by ELISA in the supernantant of DCs cultured with
medium (empty bars) or FhCL3 (10µg/ml), (blacks bars). (C) IL-1β and IL-18 secretion were evaluated in the supernatant of DCs with medium, FhCL3 (10µg/ml) or
rvFhCL3 (10µg/ml) by ELISA. Data are presented as mean ± SD from at least four wells are representative results from three experiments. ***p < 0.001 (ANOVA test).
Interestingly, the pro-IL-1β cleavage by FhCL3 seems to be site
specific since the addition of FhCL3 to the mature IL-1 β form,
did not modify the band corresponding to 17 kDa (Figure 3D).
These data show an undescribed ability of FhCL3 to cleave
pro-IL-1β through its cysteine protease activity.
The Inflammasome Activation Induced by
FhCL3 Is Dependent on NLRP3
Through inflammasome activation, the proteins of cytosolic
multimeric complexes are assembled andmediate the maturation
of IL-1β and IL-18. During inflammasome activation triggering,
cytosolic NOD-like receptors (NLRs) are able to detect PAMPs or
DAMPs, generating the active form of IL-1β and IL-18. Multiple
molecules are able to activate NLRP3 inflammasome, among
them there are PAMPS, bacterial toxins, ATP and a variety of
crystal such as monosodium urate crystal (20).
In order to evaluate if FhCL3 activates the NLRP3
inflammasome, in vitro culture using NLRP3-deficient DCs
(NLRP3 KO) were performed. As shown in Figures 4A,B, in
the absence of NLRP3 a partial, but significant inhibition of
IL-1β and IL-18 production was observed in comparison to that
produced by DCs from WT mice (p < 0.001 WT vs. NLRP3
KO mice). Since the bioactive molecule of IL-1β is available
only after the cleavage of pro-IL-1β by caspase-1, a key effector
molecule of the inflammasome, we tested its role in FhCL3-
induced inflammasome activation. Unexpectedly, IL-1β and
IL-18 secretion were not modified in FhCL3-treated DCs from
CASP1/11KO (caspase 1/11 deficient mice), compared to that
produced by WT DCs. In contrast, LPS/ATP-treated DCs from
CASP1/11 KO or NLRP3 KO mice showed a significant decrease
in IL-1β and IL-18 secretion (Figures 4A,B). Since some studies
show that other caspases than 1 and 11, such as the caspases 4 and
5, are able to activate the NLRP3 inflammasome, we evaluated
the production of IL-1β in FhCL3-treated DCs in the presence
of the pan-caspase inhibitor Z-VAD-FMK. We observed that
in spite of a complete inhibition of caspase activity, FhCL3 was
still able to induce IL-1β production in DCs, corroborating
the lack of involvement of caspases in this phenomenon
(Figure 4C). Moreover, TNF and IL-12p70 production by
LPS/ATP-stimulated DCs was unaffected by the absence of CASP
1/11 or NLRP3 (Supplementary Figures 3A,B). These results
indicate that the inflammasome activation induced by FhCL3 is
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FIGURE 2 | Intracellular location of FhCL3, analyzed by Confocal Laser Scanning Microscope. DCs were incubated for 30min, 4 h or 18h with Alexa
Fluor®488-labeled FhCL3 (green) to evaluate co-localization with early endosomes and lysosomes, respectively. (A) Cells were stained with EEA-1, early endosomal
antigen 1, in red. Orthogonal projections of z-stacks are depicted. The cell nucleus was used as an internal reference point. The XZ and YZ planes show the cell height
and width, and height and length, respectively. (B,C) LAMP, in lysosomes are showed red at 4 h and after 18 h, respectively. Cell Nuclei were stained with Hoechst.
Higher magnifications of selected areas are shown on the right. These images are representative at least two experiments. The scale bar is 10 micron in (A) and 5
micron in (B,C).
partially dependent on NLRP3, however, it is uncoupled from
caspase activation.
FhCL3 Induces IL-1β Through ROS
Production, Potassium (K+) Efflux and
Lysosomal Acidification
Considering the fact that reactive oxygen species (ROS)
production is a crucial event that triggers the inflammasome
activation (37), we decided to evaluate its involvement in the
FhCL3-induced DCs activation. To elucidate the role of these
intermediary signals, DCs were treated with FhCL3 or LPS for 4
or 18 h, in the presence or absence of ATP during the last 30min
of culture, and the expression of mitochondrial ROS (mROS)
and cytoplasmic ROS (cROS) was determined by flow cytometry.
As shown in Figure 5A, FhCL3-conditioned DCs displayed an
increase in the mean fluorescence intensity (MFI) of these
cells expressing both mitochondrial (left panel) and cytoplasmic
(right panel) ROS, when compared to the unstimulated control.
The increase in mROS was observed at earlier times (4 h) in
comparison to the cROS production (18 h). Similar results were
observed in LPS-treated DCs for 4 h or 18 h followed by the
addition of ATP (Figure 5A).
In order to study whether IL-1β production induced by
FhCL3-treated DCs depends on ROS or not, we used a NADPH
oxidase inhibitor, which is a critical enzyme involved in ROS
production. First, DCs were pretreated with the NADPH oxidase
inhibitor diphenyleneiodonium (DPI) for 30min . Subsequently,
the cells were stimulated with medium, FhCL3 or LPS/ATP.
The inhibition of ROS production drastically reduced the
amounts of IL-1β secreted by FhCL3-treated DCs (Figure 5B).
Similar results were observed when DCs were treated with
potassium chloride (KCl) to block potassium (K+) efflux,
whereas a partial inhibition in IL-1β production was observed
after the chloroquine treatment of DCs to inhibit lysosomal
acidification (Figure 5B). These findings strongly suggest that
ROS production, potassium (K+) efflux as well as lysosomal
acidification are all events involved in FhCL3-induced IL-1β
production in DCs.
DCs Conditioned With FhCL3 Show
Increased T-Cell Allostimulatory Capacity
Promoting IFN-γ and IL-13 Responses
Then, wewanted to evaluate which T helper profile was promoted
by FhCL3-treated DCs in a mixed lymphocyte reaction. To this
end, FhCL3-treated DCs from C57BL/6 mice, were cultured with
allogeneic splenocytes from BALB/c. Cultures with untreated
DCs were used as control.
After 18 h of culture, increased amounts of IFN-γ and IL-
13 were detected in the supernatant of allogeneic cultures when
DCs were stimulated with FhCL3. However, the levels of these
two cytokines were not modified after rvFhCL3-treated DCs
stimulation (Figure 6A). Besides, no changes in IL-4 production
were detected in allogeneic cultures with FhCL3-treated DCs
(Figure 6A). The analysis of allogeneic splenocytes after cultured
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FIGURE 3 | FhCL3 promotes the expression, proteolysis and secretion of IL-1β without LPS or ATP stimulation. (A) DCs were stimulated with medium, FhCL3
(10µg/mL) and/or LPS (100 ng/mL) for 18 h; in same cases ATP (5mM) was added the last 30min of culture. IL-1β and IL-18 production were quantified by ELISA in
culture supernatants. (B) DCs were treated with medium, FhCL3 (10µg/mL) and/or LPS (100 ng/mL) for 2 or 4 h. mRNA levels of IL-1β were determined by q-PCR
relative to the housekeeping gene β-actin and normalized to the level of unstimulated DCs. (C) Recombinant pro-IL-1β (31 kDa) was incubated at 37◦C in sodium
phosphate buffer, with or without FhCL3 (0.5, 2 or 6 ng/mL) or rvFhCL3 (2 or 6 ng/mL) for 2 h. Mature IL-1β levels were determined in supernatants by capture ELISA.
Recombinant IL-1β (17 kDa) was used as positive control and represents the commonly detected mature form, whereas pro-IL-1β indicates the inactive
pro-form. (D) Western blot illustrating the cleavage of pro-IL-1β by FhCL3 or rvFhCL3 (1µg/mL). Recombinant IL-1β (17 kDa) or pro-IL-1β (37 kDa) were loaded as
controls. The graph bars show the densitometry analysis of IL-1β (17 kDa) from two experiments with similar results. Bars panels show the mean ± SD and are
representative of three or two independent experiments. ND, not detected; *p < 0.05; **p < 0.01; ***p < 0.001 (ANOVA test).
with FhCL3-treated DCs by flow cytometry showed an increase
in T CD4 (from 0.6 to 3.9%) and T CD8 (from 0.5 to 6.5%)
IFN-γ expressing cells, compared to the response of
splenocytes incubated with untreated DCs (Figure 6B). Similar
results were observed with DCs from BALB/c mice pulsed with
FhCL3 in cultures with splenocytes from C57BL/6 animals (data
not shown).
Due the involvement of NLRP3 in FhCL3-induced DCs
inflammasome activation, we evaluated the T cell allostimulatory
capacity of DCs from NLRP3 KO mice. In agreement with
the results showed above, the ability of FhCL3-treated DCs to
prime T cells response diminished in the absence of NLRP3,
since IFN-γ level was significantly lower than that induced
by DCs from WT mice (Figure 6B). In contrast, DCs from
CASP1/11 KO mice were able to induce similar levels of IFN-
γ production by splenocytes in cultures with DCs from WT
mice (Figure 6C). The capacity of FhCL3-treated DCs from
NLRP3 or CASP1/11 KO to induce IL-13 secretion by allogeneic
splenocytes was similar to that produced in allogeneic cultures
with WT DCs (Figure 6C).
These data indicate that DCs stimulated with FhCL3
prime splenocytes toward a singular profile characterized
by high levels of IFN-γ and IL-13, with this capacity
depending on the cysteine protease activity of FhCL3.
In addition, the ability to induce IFN-γ of FhCL3-
conditionated DCs is independent of caspases 1/11 and
dependent on NLRP3, suggesting a non-canonical activation of
the inflammasome.
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FIGURE 4 | FhCL3 enhances IL-1β and IL-18 secretion in DCs by a NLRP3
dependent and caspase independent mechanism. (A) and (B) DCs from WT,
CASP1/11 KO or NLRP3 KO mice were stimulated with medium or FhCL3
(10µg/mL) for 18 h. In some cultures the cells were treated with LPS
(100 ng/mL) for 18 h and ATP (5mM) for the last 30min of culture. IL-1β and
IL-18 production were evaluated by ELISA in culture supernatants. Bars
panels represent the mean ± SD from three independent assays ND, not
detected; ***p < 0.001(ANOVA with Dunnett’s post-test). (C) DCs pretreated
or not with pan caspase inhibitor (Z-VAD-FMK, 5µM, 1h) were incubated with
FhCL3 or LPS in the presence or absence of ATP during the last 30min of a
18 h stimulation period. IL-1β secretion was quantified by ELISA in
supernatants. The bars represent a ratio of IL-1β detected in culture
supernatant of DCs with different stimuli vs. unstimulated DCs. Experiment
was repeated three times with similar results being obtained and is expressed
in bars graph, as the mean ± SD.
FhCL3-treated DCs Induce Increased IFN-γ
Secreting T Cells in vivo
Next, we explored the ability of FhCL3-treated DCs to induce a
specific T cell response in lymph node of mice injected with these
cells. After 7 days of intraperitoneally administration, iLN were
removed, and suspensions of lymphocytes were restimulated
with FhCL3 for 48 h. Significantly increased levels of IFN-γ and
IL-13 were detected in the supernatant of iLN cultures of mice
injected with FhCL3-treated DCs (Figure 7A). Additionally,
mice injected with FhCL3-treated DCs, mounted a specific CD8-
IFN-γ expressing T cell response and to a lesser extent.
CD4-IFN-γ in T cells present in iLN (Figure 7B), in
comparison with cells from iLN of mice injected with untreated
DCs. In contrast, mice injected with LPS-stimulated DCs, failed
to develop a specific IFN-γ against FhCL3 (Figure 7B). These
data indicate that FhCL3-treated DCs can prime T cells from iLN
in vivo toward a specific response characterized by IFN-γ and
IL-13 cytokine profile.
DISCUSSION
IL-1β is synthesized as an inactive form of 31 kDa precursor,
termed pro-IL-1β, after recognition of PAMPs. Processing of
bioactive IL-1β (and that of IL-18) depends on caspase-1
activation by protein complexes called inflammasomes (38). The
activity of cysteine protease of caspase-1 raised the question of
whether other enzymes coming from cells or microorganisms
have the ability to process pro-IL-1β or not. Indeed, some studies
have showed that neutrophil- and macrophage-derived serine
proteases such as a neutrophil serine protease, proteinase-3,
elastase, and cathepsin-G enzymes are able to process pro-IL-
1β into 17 kDa active fragment (39, 40). In addition, matrix
metalloproteinases (MMP), such as stromelysin 1, gelatinases
A and B, have also shown the ability to cleave pro-IL-1β
(41). Similarly, studies using either blastospores or hyphae
from Candida albicans in the presence of proteinase inhibitors,
revealed that the cleavage of pro-IL-1β involves the participation
of aspartyl proteinases (42). Interestingly, the ability to induce IL-
1β production in the infection with Mycobacterium tuberculosis,
showed the existence of alternative pathways of IL-β and IL-18
activation by a mechanism that does not require TLR signaling
or caspase-1(43). Despite these reports, much less information
is available about the capability of helminth-derived proteases to
modulate inflammasome activation.
In the present study, it was the first time that a cysteine
protease from a helminth parasite was found to induce
an inflammasome alternative activation, which causes the
production of IL-1β and IL-18 in DCs. This statement is based on
experiments showing that FhCL3 did not follow the conventional
steps of activation described for the IL-1β synthesis during
innate immune responses toward different pathogens. It is well-
known that two signals are required to induce inflammasome
activation: the signal one, induced by PAMPs or DAMPs derived
from tissue damage, which in turn activates innate immunity
receptors such as TLR and lead to the synthesis of pro-IL-
1β depending on NF-kB activation (20). The induction of IL-
1β by FhCL3 treatment, did not require priming signals since
the mere presence of the enzyme was a sufficient stimulus to
increase the production of this cytokine, and did not change
when LPS or ATP was added to the DCs cultures. Despite the
independence of NF-kB in FhCL3-induced DCs activation, the
expression of the gene coding for IL-1β increased more than
20 times, in relation to the basal condition in unstimulated
DCs. Interestingly, these findings are consistent with a recent
study which has demonstrated that endogenous cathepsins are
implicated in the nigericin-induced inflammasome activation,
since they can induce both: pro-IL-1β synthesis and NLRP3
activation (44). The lack of involvement of NF-kB in FhCL3-
induced DCs activation, suggests that other/s transcription factor
might be involved in the synthesis of pro-IL-1β. In this respect,
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FIGURE 5 | ROS production, potassium (K+) efflux and lysosomal acidification are involved in FhCL3-induced IL-1β production in DCs. (A) DCs were stimulated with
medium, FhCL3 (10µg/mL) or LPS (100 ng/mL) plus ATP (5mM) for 4 or 18 h. ATP was added the last 30min of culture. Cells were stained with anti-CD11c and
anti-MHCII antibodies. Then, DCs were incubated with 5µM MitoSOX probe (PE) or 20µM H2DCFDA probe for 20min at 37◦C, and analyzed by Flow cytometry.
Histograms represent mean fluorescence intensity (MFI) of mROS and cROS on CD11c+ MHCII+ gated populations with different treatments. Bars depict the mean
± SD and are representative of at least three independent experiments. (B) DCs pretreated or not with DPI (20µM, for 3 h), KCl (50mM, for 90min) or choloroquine
(5mM for 1 h), were stimulated with FhCL3 (10µg/mL) for 18 h. Then IL-1β secretion was quantified by ELISA in supernatants. Experiments were repeated three times
with similar results being obtained and are expressed as in bars graph mean ± SD ND, not detected; *p < 0.05; **p < 0.01; ***p < 0.001 (ANOVA test).
either IFN regulatory factors IRF-4 or IRF-8 has been involved
in the IL-1β transcription and more recently the kinase CK2
has been described as a master regulator of two independent
pathways that promote IL-1β transcription, one of the pathway
was dependent on NF-kB p65 and the other dependent on IRF4
activation (43). More experiments should be performed, in order
to evaluate possible candidates that mediate FhCL3-induced pro-
IL-1β synthesis.
The second signal of inflammasome activation, promotes
the oligomerization of the receptors belonging to the NOD-
like receptors (NLRs) family, being the most studied the
pyrin domain-containing protein 3 or NLRP3 (45, 46). The
subsequent assembly of NLRP3, ASC and procaspase-1 into a
complex, constitute the scaffold that mediates the generation of
inflammatory caspases. The latter is involved in the processing
of pro-IL-1β and the pro-IL-18 toward its active forms. The
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FIGURE 6 | FhCL3-treated DCs induce an IFN-γ and IL-13 response in allogeneic cultures. DCs from WT, CASP1/11 KO or NLRP3 KO (all C57BL/6 background)
were treated with medium, FhCL3 (10µg/mL) or rvFhCL3 (10µg/mL) for 18 h and co-cultured with allogeneic splenocytes from BALB/c mice. (A) At day 5, IFN-γ, IL-4
and IL-13 concentrations were measured in supernatants by ELISA. (B) The splenocytes were stimulated with PMA/Ionomycin for 4 h and analyzed by flow cytometry.
IFN-γ expression was evaluated on CD4+ and CD8+ T cells on CD3+ gated population by flow cytometry. Data are showed in representative dot plot diagram of
three or four independent experiments. In the upper quadrants the values indicate the percentages as mean ± SD. (C) IFN-γ and IL-13 production were determined in
culture supernatants by ELISA. The concentrations were normalized according to a ratio of IFN-γ or IL-13 detected in culture supernatant of allogeneic splenocytes
cultured with FhCL3-treated DCs vs. unstimulated DCs. Results are presented in bars graph as means ± SD and are representative of three experiments. NS, not
significant, *p < 0.05; **p < 0.01; ***p < 0.001 (ANOVA test).
potassium efflux (47), the lysosomal disruption that leads to
release of cathepsin B into the cytosol (48) and the intracellular
generation of reactive oxygen species (ROS) (49) are among
the signals capable of inducing the assembly of the NLRP3
inflammasome. In this work, the inhibition of ROS production,
potassium efflux and the lysosomal acidification caused a
decrease in the IL-1β secreted by FhCL3-treated DCs, which
suggests the involvement of these mediators in inflammasome
activation. However, the ability of activated DCs to produce IL-
1β was not dependent on caspases. This ability was demonstrated
by the use of DCs from deficient mice in caspases 1 and 11, as
well as the pan caspase inhibitor Z-VAD-FMK, which was able to
block other caspases such as 4 and 5 involved in inflammasome
activation, suggesting the involvement of other enzyme different
to caspase in the cleavage of pro-IL-1β. This hypothesis, was
clearly demonstrated when an inactive recombinant form of
FhCL3 was unable to induce IL-1β production in DCs. These
data were confirmed in a free cell system in which an active
recombinant form of FhCL3 was capable to cleave a pro-IL-1β
recombinant to its active form of IL-1β that was detected by
ELISA and western blot.
After being endocyted, helminth molecules, such as SEA
of S. mansoni and the filarial antigen ES-62, are located in
LAMP1+ vesicles on DCs and macrophages, respectively (29,
50). However, only a weak colocalization with lysosomes was
evidenced after endocytosis of FhCL3, which persisted within
the cells at least 18 h post-incubation. It has been described that
FhCL1 is internalized by peritoneal macrophages, and unlike
FhCL3, presents a greater localization within early endosomes.
Due to the poor colocalization of FhCL3 with endosomes or
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FIGURE 7 | FhCL3-treated DCs promote a specific IFN-γ response in vivo. C57BL/6 mice were injected intraperitoneally with DCs treated or not with FhCL3 or LPS.
At day 7, cells from iLN were obtained and re-stimulated with FhCL3 for 48 h. (A) The cells were stimulated with PMA/Ionomycin for 4 h and analyzed by flow
cytometry. The IFN-γ production was evaluated in CD4+ and CD8+ T cells on CD3+ gated population from inguinal lymph node. Data of flow cytometry are showed
in representative dot plot diagram of three independent experiments. To the right, bar graphs depict the frequency of gated T cells. (B) The IL-4, IL-13 and IFN-γ
production were evaluated in culture supernatant by ELISA. Results are presented in bars graph as means ± SD and are representative of three experiments.
*p < 0.05; **p < 0.01; ***p < 0.001 (ANOVA test).
lysosomes, the mechanism of endocytosis could be different from
that used by FhCL1. Considering that FhCL3 is a molecule of low
molecular weight, the entry into the cell could be mediated by
a mechanism of pinocytosis. However, the use of a pinocytosis
inhibitor (cytochalasin D), in cultures of DCs treated with
FhCL3, did not affect either the entrance of the cells, or the
production of IL-1β (data not shown), suggesting that FhCL3
could be endocyted trough a receptor pathway.
Even though FhCL3 induces an increase in the production of
cytokines considered as pro-inflammatory such as IL-1β or IL-18,
it does not generate a fully activation on DCs, since other typical
inflammatory cytokines as well as co-stimulatory molecules were
not increased. Meanwhile only a partial up-regulation of MHCII
was observed. This increase could be explained by a mechanism
that correlates IL-1β secretion and the release of the MHCII to
the cell membrane, being these events absolutely necessary to the
inflammasome assembly (51)
The involvement of NLRP3 in the FhCL3-induced DCs
IL-1β production, could be explained in two different ways:
on the one hand, a direct interaction between FhCL3 and
NLRP3 could occur during the inflammasome activation. Further
experiments should be performed to confirm this hypothesis.
On the other hand, ROS production, potassium efflux and
lysosomal disruptionmight act as intermediaries in the activation
of NLRP3 inflammasome. These data, together with the cytosolic
location, suggest that FhCL3 would have a caspase like activity
in DCs during the inflammasome activation. In contrast, data
published by Alvarado et al. show that FhHDM-1, a cathelicidin-
like peptide secreted by F. hepatica, inhibits the inflammasome
activation by a mechanism depending on lysosomal acidification
(23). Within the 24 h after the infection with F. hepatica, the
recruitment of alternative macrophages (M2) in the peritoneum
of infected animals is induced by a predominant Th2 response
(52, 53). However, an excessive response could be deleterious
for the parasite. The IL-1β secretion, which controls the innate
cytokines IL-25 and IL-33 production, both critical for the Th2
promotion, has been proposed as a mechanism to assure the
chronicity of the parasite in intestinal infections by nematodes.
A similar phenomenon might be possible during fasciolosis,
since FhCL3 expressed by the juvenile worm could induce IL-1β,
while FhHDM-1 secreted in all the stages (54) would control the
function of the inflammasome. FhHDM-1, together with Fh12
(55), thioredoxin peroxidase (52) and kunitz type molecule (10),
among others inhibitory molecules, could lead to a permanent
suppression of inflammation during F. hepatica infection. In vitro
experiments trying to dissect how FhCL3 and FhHDM-1 regulate
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the function of the inflammasome should be performed. In vivo
silencing of FhCL3 using RNA interference in the infective stage,
can causes a reduction in the penetration capacity of juvenile
larvae through the intestinal wall interfering the life cycle of the
parasite (56).
The treatment of the DCs with FhCL3, conditions these
cells to stimulate the production of IFN-γ and IL-13 in
allogeneic splenocytes. In this work, it was established that
the main source of IFN-γ were CD8T lymphocytes and
to a greater extent, CD4T cells. The dependence of this
inflammasome was determined by the reduced ability of NLRP3
deficient DCs to promote the production of IFN-γ in cultures
with allogeneic splenocytes. These results are in line with
evidences showing that the deficiency of NLRP3 in mice
infected with Trichuris muris, correlates with a reduced IFN-
γ response, increased type 2 responses, and consequently the
worm expulsion is accelerated (57). These data highlight the
important role of NLRP3 in limiting protective immunity to
this helminth.
The lack of dependence between NLRP3 inflammasome
activation in DCs and the polarization of the response of IL-13
in allogenic lymphocytes, could be due to the opposing functions
of IL-1β and IL-18 on the synthesis of IL-13. While some reports
show the involvement of IL-18 in the up-regulation of IL-13 (58),
others indicate an inhibitory role of IL-1β (13).
A question that arises from the comparison between the
inflammasome activation of antigen presenting cells (APC)
after infection with intracellular pathogens such as bacteria
or protozoa and the inflammatory activation produced by
extracellular pathogens such as helminths, is the fate of the
APC after the inflammatory process (59). In contrast, very little
information is available about the destination of the cells after
inflammasome activation in helminth infections. In this respect,
in our work we did not observe an increase in LDH, which is
an enzyme released as a measure of pyroptosis (60), in FhCL3-
treated DCs. In agreement with these data, Alvarado et al. have
shown the ability of FhHDM-1 to diminish LDH release in LPS
stimulated macrophages, which suggest that these cells would not
die by pyroptosis.
In summary, this is the first report that describes a
molecule derived from F. hepatica, FhCL3, with the ability to
promote an alternative activation of the NLRP3 inflammasome,
independently of caspase activity, which is characterized by the
release of both, IL-1β and IL-18. These events have consequences
on the adaptive immune responses, given that FhCL3-treated
DCs promote a signature profile pattern of cytokines IFN-
γ and IL-13 that could turn out to be protective in this
parasitosis. Thus, this study may provide useful information for
vaccines designing.
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Supplementary Figure 1 | FhCL3 biochemical features. (A) Determination of
FhCL3 activity by hydrolysis of Tos-GPR-AMC. Initial rates were measured at 60-s
intervals for 20min and plotted as Relative Fluorescence Units (RFU) of AMC
released from substrate per unit of time (min). (B) Mass spectrometric analysis by
matrix-assisted laser desorption ionization time-of-flight mass spectrometry
(MALDI-TOF MS) of FhCL3. The recombinant analysis identifies two peaks
correspond to 29 kDa and 38,6 kDa consistent with molecular mass of the active
enzyme and proenzyme, respectively.
Supplementary Figure 2 | FhCL3 does not modify the expression of
co-stimulatory molecules and NF-κB activation. (A) DCs were cultured with
medium, FhCL3 (10µg/mL) or LPS (100 ng/mL) for 18 h. Expression level of MHCI
and co-stimulatory molecules CD40, CD80, and CD86 were evaluated by flow
cytometry. Data are showed in representative histogram of three independent
experiments. Values indicating mean fluorescent intensity (MFI) and percentage of
expression. Below, bar graphs depict fold change MFI respect to unstimulated
DCs. Bar graphs shown means ± SD (ANOVA test ∗p < 0.05; ∗∗p < 0.01;
∗∗∗p < 0.001). (B) DCs were stimulated with medium, FhCL3 or LPS for 10 or
30min. p65 and IkB-α expression were evaluated by western blotting. The blot is
representative of two experiments with similar results.
Supplementary Figure 3 | (A,B) DCs from WT, CASP1/11 KO or NLRP3 KO
mice were stimulated with medium or FhCL3 (10µg/mL) for 18 h. In some cultures
the cells were treated with LPS (100 ng/mL) for 18 h and ATP (5mM) for the last
30min of culture. TNF and IL-12p70 production were evaluated by ELISA in
culture supernatants. Bars panels represent the mean ± SD from three
independent assays (ND, not detected; ANOVA with Dunnett’s post-test).
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